BIT 0.00% 3.4¢ biotron limited

Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives, page-21

  1. 986 Posts.
    lightbulb Created with Sketch. 310
    The answers you seek require more trials and more $$ and hell of a lot more time. Without a partner this is a never ending tin rattling escapade to keep MM living a luxurious life working from her holiday home and endless knitting. These trials should be delivering more convincing evidence by now.... all I am hearing is .... "while not demonstrating a rise in CD4 cells, are of interest and *may* portend clinical impact." We don't want may or might at this end of the road.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.4¢
Change
0.000(0.00%)
Mkt cap ! $30.67M
Open High Low Value Volume
3.3¢ 3.5¢ 3.3¢ $12.66K 367.6K

Buyers (Bids)

No. Vol. Price($)
1 155931 3.4¢
 

Sellers (Offers)

Price($) Vol. No.
3.6¢ 113208 2
View Market Depth
Last trade - 16.10pm 22/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.